NO991340L - Stamme-seleksjon av pneumococcale overflateproteiner, beslektede anvendelser - Google Patents

Stamme-seleksjon av pneumococcale overflateproteiner, beslektede anvendelser

Info

Publication number
NO991340L
NO991340L NO991340A NO991340A NO991340L NO 991340 L NO991340 L NO 991340L NO 991340 A NO991340 A NO 991340A NO 991340 A NO991340 A NO 991340A NO 991340 L NO991340 L NO 991340L
Authority
NO
Norway
Prior art keywords
related applications
surface proteins
pneumococcal surface
strain selection
strain
Prior art date
Application number
NO991340A
Other languages
English (en)
Norwegian (no)
Other versions
NO991340D0 (no
Inventor
Robert S Becker
David E Briles
Susan Hollingshead
Original Assignee
Connaught Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Connaught Lab filed Critical Connaught Lab
Publication of NO991340D0 publication Critical patent/NO991340D0/no
Publication of NO991340L publication Critical patent/NO991340L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
NO991340A 1996-09-20 1999-03-19 Stamme-seleksjon av pneumococcale overflateproteiner, beslektede anvendelser NO991340L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/710,749 US5955089A (en) 1993-04-20 1996-09-20 Strain selection of pneumococcal surface proteins
PCT/US1997/016761 WO1998011915A1 (en) 1996-09-20 1997-09-22 Strain selection of pneumococcal surface proteins

Publications (2)

Publication Number Publication Date
NO991340D0 NO991340D0 (no) 1999-03-19
NO991340L true NO991340L (no) 1999-05-18

Family

ID=24855364

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991340A NO991340L (no) 1996-09-20 1999-03-19 Stamme-seleksjon av pneumococcale overflateproteiner, beslektede anvendelser

Country Status (9)

Country Link
US (3) US5955089A (enExample)
EP (1) EP0956043A4 (enExample)
JP (2) JP2000503676A (enExample)
AU (1) AU726927B2 (enExample)
CA (1) CA2267343A1 (enExample)
HU (1) HUP9902457A3 (enExample)
NO (1) NO991340L (enExample)
NZ (1) NZ334811A (enExample)
WO (1) WO1998011915A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955089A (en) * 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
US7078042B2 (en) * 1995-09-15 2006-07-18 Uab Research Foundation Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US20010016200A1 (en) * 1998-04-23 2001-08-23 Briles David E. Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor
US7038035B1 (en) * 1998-06-19 2006-05-02 Government Of Republic Of Singapore Vaccine-induced hepatitis B viral strain and uses thereof
EP1034792A1 (en) * 1999-03-11 2000-09-13 Pasteur Merieux Serums Et Vaccins Intranasal delivery of pneumococcal polysaccharide vaccines
JP2004503565A (ja) * 2000-06-14 2004-02-05 サイトヴァックス・バイオテクノロジーズ・インコーポレーテッド 構造特異的ペプチドを生産するためのコイルドコイル構造的骨格の使用
US7574495B1 (en) * 2000-09-13 2009-08-11 Fortinet, Inc. System and method for managing interworking communications protocols
US7272643B1 (en) * 2000-09-13 2007-09-18 Fortinet, Inc. System and method for managing and provisioning virtual routers
US20040116661A1 (en) * 2000-10-26 2004-06-17 Holden David William Streptococcal genes
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
ES2302926T5 (es) 2002-04-25 2012-08-23 Banner Pharmacaps, Inc. Cápsula blanda masticable
US7376125B1 (en) * 2002-06-04 2008-05-20 Fortinet, Inc. Service processing switch
US7203192B2 (en) * 2002-06-04 2007-04-10 Fortinet, Inc. Network packet steering
US7096383B2 (en) 2002-08-29 2006-08-22 Cosine Communications, Inc. System and method for virtual router failover in a network routing system
AU2004269320B2 (en) 2003-06-20 2009-12-24 Protein Sciences Corporation Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
US7304139B2 (en) * 2003-10-28 2007-12-04 University Of Florida Research Foundation, Inc. Polynucleotides and polypeptides of Anaplasma phagocytophilum and methods of using the same
US7499419B2 (en) 2004-09-24 2009-03-03 Fortinet, Inc. Scalable IP-services enabled multicast forwarding with efficient resource utilization
US7808904B2 (en) * 2004-11-18 2010-10-05 Fortinet, Inc. Method and apparatus for managing subscriber profiles
WO2009103312A1 (en) * 2008-02-19 2009-08-27 Ludwig-Maximilians-Universität Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
ES2325243B1 (es) * 2008-02-27 2011-05-04 Universidad De Granada Antigeno recombinante.
CU23919B1 (es) * 2010-09-28 2013-07-31 Ct De Ingeniería Genética Y Biotecnología Composición vacunal para el control de las infestaciones por ectoparásitos
CA3219727A1 (en) * 2010-12-22 2012-06-28 Intervet International B.V. Vaccines comprising live aro mutant bordetella bronchiseptica
ES2763415T3 (es) * 2012-09-19 2020-05-28 Univ Osaka Vacuna neumocócica que contiene proteína A superficial neumocócica
CN104306965B (zh) * 2014-10-31 2017-05-10 康希诺生物股份公司 预防肺炎链球菌感染性疾病的免疫原性组合物及制备方法
AU2017366726B2 (en) 2016-12-03 2021-12-09 The Uab Research Foundation Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4496538A (en) 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
US5019384A (en) 1986-06-30 1991-05-28 Massachusetts Institute Of Technology Immunonodulating compositions and their use
US5476929A (en) 1991-02-15 1995-12-19 Uab Research Foundation Structural gene of pneumococcal protein
US5679768A (en) 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5955089A (en) 1993-04-20 1999-09-21 Uab Research Foundation Strain selection of pneumococcal surface proteins
CA2116261A1 (en) 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a

Also Published As

Publication number Publication date
EP0956043A4 (en) 2002-10-30
JP2003002842A (ja) 2003-01-08
US7189404B2 (en) 2007-03-13
EP0956043A1 (en) 1999-11-17
NO991340D0 (no) 1999-03-19
AU726927B2 (en) 2000-11-23
HUP9902457A2 (hu) 1999-11-29
US5955089A (en) 1999-09-21
US20040067237A1 (en) 2004-04-08
WO1998011915A1 (en) 1998-03-26
JP2000503676A (ja) 2000-03-28
CA2267343A1 (en) 1998-03-26
AU4428797A (en) 1998-04-14
HUP9902457A3 (en) 2000-03-28
NZ334811A (en) 2000-09-29
US6638516B1 (en) 2003-10-28

Similar Documents

Publication Publication Date Title
NO991340L (no) Stamme-seleksjon av pneumococcale overflateproteiner, beslektede anvendelser
ID16966A (id) Sediaan antibodi pekat
DE69727162D1 (de) Herstellung von inulinhaltigen Produkten
FI933580A7 (fi) Pneumokokkiproteiinin rakennegeeni
DE69804995D1 (de) Zyklonabscheider
DE59809278D1 (de) Hysteresebremse
ID26351A (id) Isosianat-isosianat oligomerik tersumbat, pembuatan dan penggunaannya
EP0831833A4 (en) NEW 5-CYCLOPROPYL-1, 4 BENZODIAZEPINE-2-ONE
BR9606662B1 (pt) esmalte de unha.
EP0928830A4 (en) MICROBIAL GROWTH MEDIA
DK0829205T3 (da) Krydderiproduktion
DE69717829D1 (de) Zyklonabscheider
FI953527A0 (fi) Pitkänippipuristin
BR9510426A (pt) Produção de cefotaxima
NL1002962A1 (nl) Haardroger.
DE69836069D1 (de) Zweirichtungsthyristor
FI972763A0 (fi) Mutanttiproteiineja
TR199500800A2 (tr) Sekil verilmis esyalarin üretilmesi.
FI974337A0 (fi) Sykloni
TR199701666A3 (tr) Sismanliga karsi proteinler
DE59701475D1 (de) Verbindungselement
DE69634206D1 (de) Sic protein von streptococcus, ein inhibitor der komplement-vermittelten lyse
WO2000037634A3 (en) Novel polypeptides and nucleic acids encoding same
FR2752699B1 (fr) Boitier, du type boitier de maquillage
KR960036301U (ko) 지압계

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application